Access cutting-edge advanced solid tumors treatment through this clinical trial at a research site in Duarte. Study-provided care at no cost to qualified participants.
Access advanced solid tumors specialists in Duarte at no cost
This study follows strict safety protocols and ethical guidelines
All study-related advanced solid tumors treatment provided free
The purpose of this study is to establish the recommended Phase 2 dose (RP2D) and/or maximum tolerated dose (MTD), safety, pharmacokinetics (PK), pharmacodynamics (PD), and antitumor activity of ORIC-114 as a Single Agent or in Combination with Chemotherapy when administered to patients with advanced solid tumors harboring an EGFR or HER2 alteration.
Sponsor: ORIC Pharmaceuticals
Check if you qualify for this advanced solid tumors clinical trial in Duarte, CA
If you're searching for advanced solid tumors treatment options in Duarte, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Duarte research site is actively enrolling participants for this clinical trial. You'll receive care from experienced advanced solid tumors specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.